Identification of Binding Sites for Myeloid Differentiation Primary Response Gene 88 (MyD88) and Toll-like Receptor 4 in MyD88 Adapter-like (Mal)

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2013 Mar 6

PMID 23460645

Citations 25

Authors

Celia Bovijn

Anne-Sophie Desmet

Isabel Uyttendaele

Tim Van Acker

Jan Tavernier

Frank Peelman

Affiliations

Soon will be listed here.

Abstract

Upon activation, Toll-like receptor 4 (TLR4) binds adapter proteins, including MyD88 (myeloid differentiation primary response gene 88) and Mal (MyD88 adapter-like) for its signal transduction. TLR4 and the adapter proteins each contain a Toll/Il-1 receptor domain (TIR domain). In this study we used random mutagenesis and the mammalian two-hybrid method MAPPIT (mammalian protein-protein interaction trap) to identify mutations in Mal that disrupt its interaction with TLR4 and/or MyD88. Our study shows that four potential binding sites and the AB-loop in the Mal TIR domain all contribute to formation of the TLR4-Mal-MyD88 complex. Mutations in the symmetrical back-to-back Mal homodimer interface affect Mal homodimerization and interaction with MyD88 and TLR4. Our data suggest that Mal dimerization may lead to formation of potential binding platforms on the top and the side of the Mal dimer that bind MyD88 or TLR4. Mutations that affect the interaction of Mal with MyD88 also affect NF-κB activation induced by Mal overexpression. In MAPPIT, co-expression of the MyD88 TIR domain enhances Mal dimerization and Mal binding to TLR4. Similarly, co-expression of Mal and the MyD88 TIR domain strongly promotes dimerization of the TLR4 intracellular domain in MAPPIT. The different types of TIR-TIR interactions in the TLR4-Mal-MyD88 complex thus show cooperative binding in MAPPIT. We present plausible models for the TIR-TIR interactions in the TLR4-Mal-MyD88 complex.

Citing Articles

Emodin Suppresses NLRP3/GSDMD-induced Inflammation via the TLR4/MyD88/NF-κB Signaling Pathway in Atherosclerosis.

Ye B, Cai X, Liang X, Chen Y, Dai S, Huang Z Cardiovasc Drugs Ther. 2024; .

PMID: 39715879 DOI: 10.1007/s10557-024-07659-w.

Taohong Siwu decoction ameliorates atherosclerosis in rats possibly through toll-like receptor 4/myeloid differentiation primary response protein 88/nuclear factor-κB signal pathway.

Fengjin C, Peng Z, Guoying L, Weizhi Z, Yanyan Z, Daiyin P J Tradit Chin Med. 2024; 44(1):103-112.

PMID: 38213245 PMC: 10774721. DOI: 10.19852/j.cnki.jtcm.20231215.003.

Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells.

Jin Y, Nevarez-Mejia J, Terry A, Sosa R, Heidt S, Valenzuela N J Immunol. 2022; 209(7):1359-1369.

PMID: 36165200 PMC: 9635437. DOI: 10.4049/jimmunol.2200284.

Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling.

Zhou J, Xiao Y, Ren Y, Ge J, Wang X iScience. 2022; 25(7):104508.

PMID: 35754719 PMC: 9213720. DOI: 10.1016/j.isci.2022.104508.

Full-Atom Model of the Agonist LPS-Bound Toll-like Receptor 4 Dimer in a Membrane Environment.

Matamoros-Recio A, Franco-Gonzalez J, Perez-Regidor L, Billod J, Guzman-Caldentey J, Martin-Santamaria S Chemistry. 2021; 27(62):15406-15425.

PMID: 34569111 PMC: 8596573. DOI: 10.1002/chem.202102995.

References

Valkov E, Stamp A, DiMaio F, Baker D, Verstak B, Roversi P . Crystal structure of Toll-like receptor adaptor MAL/TIRAP reveals the molecular basis for signal transduction and disease protection. Proc Natl Acad Sci U S A. 2011; 108(36):14879-84. PMC: 3169156. DOI: 10.1073/pnas.1104780108. View

Gay N, Keith F . Drosophila Toll and IL-1 receptor. Nature. 1991; 351(6325):355-6. DOI: 10.1038/351355b0. View

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

Tao X, Xu Y, Zheng Y, Beg A, Tong L . An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem Biophys Res Commun. 2002; 299(2):216-21. DOI: 10.1016/s0006-291x(02)02581-0. View

Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley J . Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature. 2000; 408(6808):111-5. DOI: 10.1038/35040600. View

Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View

Miggin S, Palsson-McDermott E, Dunne A, Jefferies C, Pinteaux E, Banahan K . NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci U S A. 2007; 104(9):3372-7. PMC: 1805564. DOI: 10.1073/pnas.0608100104. View

Fitzgerald K, Palsson-McDermott E, Bowie A, Jefferies C, Mansell A, Brady G . Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 2001; 413(6851):78-83. DOI: 10.1038/35092578. View

Kagan J, Su T, Horng T, Chow A, Akira S, Medzhitov R . TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008; 9(4):361-8. PMC: 4112825. DOI: 10.1038/ni1569. View

10.

Ve T, Gay N, Mansell A, Kobe B, Kellie S . Adaptors in toll-like receptor signaling and their potential as therapeutic targets. Curr Drug Targets. 2012; 13(11):1360-74. DOI: 10.2174/138945012803530260. View

11.

Khor C, Chapman S, Vannberg F, Dunne A, Murphy C, Ling E . A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet. 2007; 39(4):523-8. PMC: 2660299. DOI: 10.1038/ng1976. View

12.

Lemmens I, Eyckerman S, Zabeau L, Catteeuw D, Vertenten E, Verschueren K . Heteromeric MAPPIT: a novel strategy to study modification-dependent protein-protein interactions in mammalian cells. Nucleic Acids Res. 2003; 31(14):e75. PMC: 167658. DOI: 10.1093/nar/gng075. View

13.

Yan J, Li Q, Lievens S, Tavernier J, You J . Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression. J Virol. 2009; 84(1):76-87. PMC: 2798453. DOI: 10.1128/JVI.01647-09. View

14.

Ulrichts P, Tavernier J . MAPPIT analysis of early Toll-like receptor signalling events. Immunol Lett. 2008; 116(2):141-8. DOI: 10.1016/j.imlet.2007.11.026. View

15.

Poltorak A, He X, Smirnova I, Liu M, Van Huffel C, Du X . Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998; 282(5396):2085-8. DOI: 10.1126/science.282.5396.2085. View

16.

Ulrichts P, Lemmens I, Lavens D, Beyaert R, Tavernier J . MAPPIT (mammalian protein-protein interaction trap) analysis of early steps in toll-like receptor signalling. Methods Mol Biol. 2009; 517:133-44. DOI: 10.1007/978-1-59745-541-1_9. View

17.

Lin Z, Lu J, Zhou W, Shen Y . Structural insights into TIR domain specificity of the bridging adaptor Mal in TLR4 signaling. PLoS One. 2012; 7(4):e34202. PMC: 3317499. DOI: 10.1371/journal.pone.0034202. View

18.

Verstak B, Nagpal K, Bottomley S, Golenbock D, Hertzog P, Mansell A . MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem. 2009; 284(36):24192-203. PMC: 2782013. DOI: 10.1074/jbc.M109.023044. View

19.

Siednienko J, Halle A, Nagpal K, Golenbock D, Miggin S . TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. Eur J Immunol. 2010; 40(11):3150-60. DOI: 10.1002/eji.201040547. View

20.

Funami K, Sasai M, Oshiumi H, Seya T, Matsumoto M . Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation. J Biol Chem. 2008; 283(26):18283-91. PMC: 2440629. DOI: 10.1074/jbc.M801013200. View